The M1 and M2 Proteins of Influenza A Virus Are Important Determinants in Filamentous Particle Formation  by Roberts, Paul C. et al.
The M1 and M2 Proteins of Influenza A Virus Are Important Determinants
in Filamentous Particle Formation
Paul C. Roberts,* Robert A. Lamb,† and Richard W. Compans*,1
*Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30322; and †Howard Hughes Medical
Institute and Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208-3500
Received August 15, 1997; accepted October 23, 1997
Influenza A virus is highly pleomorphic with particles exhibiting either spherical or filamentous morphology. The mecha-
nisms behind this pleomorphism and its importance in viral pathogenesis are not clearly understood. We have observed that
budding of filamentous influenza A/Udorn virus particles can be readily visualized by immunofluorescence microscopy.
Filamentous particle formation was inhibited by treatment of cells with the anti-M2 14C2 antibody, but was not inhibited with
the isotype identical 5C4 anti-M2 antibody or by anti-neuraminidase antibody. To further explore the viral determinants of
filamentous particle formation, we investigated the morphology and growth characteristics of three variants of A/Udorn/72
virus, which had previously been selected for their resistance to growth inhibition by the 14C2 anti-M2 monoclonal antibody.
Two of the variant viruses, 5A and 10A, contain single amino acid substitutions in the cytoplasmic domain of the M2 protein,
whereas the 1A variant contains a single amino acid substitution in the viral matrix protein, M1. Variants 5A and 10A both
were found to retain the filamentous particle phenotype found in the parental strain A/Udorn/72, and the production of
filamentous virions by both variants was resistant to inhibition by the 14C2 antibody. However, immunofluorescence and
electron microscopy revealed that the variant 1A was composed almost exclusively of spherical particles. The 1A variant
displayed higher viral yields and a larger plaque size than the filamentous viruses. In addition, we separated distinct
populations highly enriched in spherical or filamentous particles by velocity gradient centrifugation. Analysis of the protein
compositions of these particles revealed that the NP:M1 or NP:HA ratios in filamentous particles were significantly lower
than in spherical particles, but the filaments have higher levels of NP per particle. The spherical and filamentous particles
were found to have similar specific infectivity. These results indicate that the filamentous morphology of the A/Udorn virus
depends upon the matrix (M1) and/or M2 proteins. © 1998 Academic Press
INTRODUCTION
Influenza A virus morphology ranges from spherical
particles with a mean diameter of approximately 120 nm,
which are commonly found in laboratory-adapted strains,
to greatly elongated filamentous particles with lengths of
greater than several micrometers, which are commonly
found in original human isolates and early egg passages
of virus (Choppin et al., 1960; Chu et al., 1949). It has
been reported that egg adaptation of original human
isolates results in loss of the filamentous phenotype
(Burnet and Lind, 1957; Kilbourne and Murphy, 1960).
Although the genetic elements responsible for filament
formation have not been identified conclusively, recent
reports suggest that alterations in several viral structural
gene products may modulate or influence virus morphol-
ogy (Enami and Enami, 1996; Hughey et al., 1995; Jin et
al., 1997; Mitnaul et al., 1996; Smirnov et al., 1991). In
addition, the properties of the host cell itself and the host
cell microfilament actin array have also been implicated
in modulation of virus morphology (Roberts and Com-
pans, 1997). Thus, it appears that viral morphology is
determined in part by interactions between viral struc-
tural proteins and cytoskeletal components of the host
cell.
A monoclonal antibody to the M2 protein designated
14C2 has been shown to restrict growth of influenza
A/Udorn virus, both in vivo by passively transferred anti-
body (Treanor et al., 1990) and in vitro by plaque size
reduction (Zebedee and Lamb, 1988, 1989). Treatment of
infected cells with this antibody was also shown to inhibit
viral assembly and release (Hughey et al., 1995). Several
A/Udorn virus variants that are resistant to the inhibitory
effects of this anti-M2 antibody have mutations within viral
RNA segment 7, which codes for the M1 and M2 proteins.
Reassortment analysis of antibody-resistant variants re-
vealed that the resistance to antibody-induced effects on
virus growth can be attributed to mutations in segment 7 of
the viral genome (Zebedee and Lamb, 1989).
In the present study, we have further investigated the
effect of the inhibitory 14C2 antibody directed against the
N-terminal extracellular domain of the M2 protein on viral
morphology, assembly, and release. We have utilized
immunofluorescence microscopy in conjunction with
biochemical characterization to further investigate the
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requirements for filamentous particle production. M2 an-
tibody-resistant variants of A/Udorn/72 virus were inves-
tigated for their ability to retain the filamentous pheno-
type of the parental virus in cell culture. Three variants
with single amino acid exchanges in the segment 7 gene
products were evaluated for growth properties, morpho-
logical phenotype, antibody-induced inhibition of fila-
ment formation, and virion protein compositional differ-
ences. The results provide new insights into viral and
cellular protein interactions involved in determining in-
fluenza virus morphology.
MATERIALS AND METHODS
Cells and viruses
Madin–Darby canine kidney cells (MDCK) were grown
and maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS; Hyclone). Influenza virus A/Udorn/301/72 and anti-
body-resistant variants 1A, 5A, and 10A (Zebedee and
Lamb, 1989) were propagated either in MDCK cells in the
presence of 1.5 mg/ml TPCK–trypsin (Sigma) or in the
allantoic sac as described previously (Zebedee and
Lamb, 1989) and stored as stock virus in the presence of
1% bovine serum albumin at 270°C until use. Infectivity
titers were determined by plaque assay in MDCK cells in
an agar overlay system containing 1.5 mg/ml of TPCK-
treated trypsin (Tobita et al., 1975). An allantoic stock of
influenza A/FW/1/50 was a kind gift from Drs. J. Katz and
N. Cox (Influenza Branch, Centers for Disease Control,
Atlanta, GA).
Antibodies
Guinea pig anti-Udorn antisera, goat anti-HA (H3 se-
rotype), anti-NA (N2 serotype), anti-M1, and anti-RNP
specific antisera were obtained from the Influenza Virus
Repository, National Institute of Allergy and Infectious
Diseases (Bethesda, MD). Anti-NP monoclonal antibody
was kindly provided by Dr. J. Katz (CDC, Atlanta, GA).
Anti-14C2 and anti-5C4 monoclonal antibodies specific
for the influenza virus M2 protein have been described
previously (Zebedee and Lamb, 1988; Holsinger and
Lamb, 1991).
Virus infection in the presence of antibodies
MDCK cells were infected with A/Udorn/72 or variant
viruses at a multiplicity of infection (m.o.i.) of 3 plaque-
forming units (PFU) per cell. Following an adsorption
period of 1 h at 37°C, the cells were further incubated in
DMEM supplemented with 2% FBS for an additional 1.5 h
prior to the addition of antibody to the incubation media.
At 2.5 h pi, specific viral antisera (goat anti-N2, mouse
14C2 anti-M2, or mouse 5C4 anti-M2 antibody) or non-
specific control antibody (goat serum or mouse anti-
isotype IgG1 antibody) were diluted 1:100 in DMEM/2%
FBS and the infections were continued in the presence of
antisera until 9 h pi. Cells were subsequently processed
for indirect immunofluorescence as described below.
Immunofluorescence
Cultures of MDCK cells grown on glass coverslips
were infected with influenza virus at a m.o.i. of 3 PFU per
cell. After an 8-h incubation in DMEM/2% FBS, the cells
were washed three times with PBS and stained for cell
surface viral antigen by sequential incubations with an-
tiserum specific for M2, HA, or NA at 4°C, followed by
fluorescein isothiocyanide (FITC)-conjugated or rhoda-
mine tetramethylisothiocyanide (TRITC)-conjugated rab-
bit anti-goat or goat anti-mouse immunoglobin Ig. Alter-
natively, cells were incubated with guinea pig anti-Udorn
antisera followed by FITC- or TRITC-conjugated goat
anti-guinea pig Ig. Following cell surface staining, cells
were fixed with 3% freshly made paraformaldehyde in
PBS for 15 min at RT. Internal viral structural proteins
were visualized by fluorescence staining of fixed cells
permeabilized either by treatment with 0.2% Triton X-100
in PBS for 15 min or by a 2-min treatment with acid:
alcohol (95% ethanol:5% glacial acetic acid, at 220°C).
Cells were mounted in Mowiol (Calbiochem) and photo-
graphed with a Zeiss Axiophot microscope equipped
with epifluorescence or dual fluorescence filters (Omega
Optical).
Metabolic labeling of viral proteins and virus particles
Influenza virus-infected cells (m.o.i. 5 3) were incu-
bated in DMEM/2% FBS. Prior to labeling, cells were
incubated for 15 min in Eagle’s medium deficient in
methionine and cysteine. Cells were subsequently la-
beled for 20 min at 37°C in Eagle’s deficient medium
supplemented with 50 mCi 35S cell labeling mix (Amer-
sham). Following labeling, monolayers were washed
twice with PBS and lysed in 200 ml of lysis buffer con-
taining 1% Triton X-100 and 0.5% sodium deoxycholic
acid in MNT [20 mM 2-(N-morpholino)ethanesulfonic
acid (MES, Sigma), 100 mM NaCl, 30 mM Tris–HCl (pH
8.0)], 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluo-
ride. Chymostatin, pepstatin, leupeptin, and antipain
(Sigma) were routinely included as protease inhibitors
(10 mg/ml). Aliquots of cell extracts were analyzed by
SDS–13.5% polyacrylamide gel electrophoresis (SDS–
PAGE) and fluorography.
For labeling of virus particles, influenza virus-infected
cells (six-well plates) were metabolically labeled from 5
to 16 h pi with 100 mC/ml 35S cell labeling mix in Eagle’s
deficient medium at 37°C. Supernatants were collected
and precleared of cellular debris by centrifugation for 5
min at 500 g at 4°C prior to analysis of virus by sucrose
gradient centrifugation.
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Sucrose gradient analysis of virus particles
After a 16-h infection in MDCK cells (m.o.i. 5 3), the
supernatants of infected cells were harvested and pre-
cleared by centrifugation at 300g for 10 min at 4°C. Virus
was pelleted through 25% sucrose cushion at 100,000g
for 1 h at 4°C. Pelleted virus was resuspended slowly
overnight at 4°C in TNE (20 mM Tris–HCl, pH 8.0, 150
mM NaCl, and 1 mM EDTA) and layered over a continu-
ous 20–60% sucrose gradient. Virus was then separated
by velocity centrifugation at 100,000g for 2.5 h at 4°C.
Virus was recovered by fractionation into 0.5-ml frac-
tions. When radiolabeled virus was analyzed, the cpm
per fraction was determined by scintillation counting of
50-ml aliquots of each fraction. Hemagglutination assay
was performed on fractions in parallel as described
previously (Compans et al., 1969). Virus was concen-
trated from pooled or individual fractions by ultracentrif-
ugation at 100,000g for 1 h at 4°C.
Electron microscopy of viral particles
For negative staining, virions in culture media or from
sucrose gradient fractions were allowed to adhere to
carbon/formvar grids and stained for 15 s with 1% am-
monium phosphotungstate, pH 7.4. Specimens were
viewed with a Philips CM10 electron microscope. The
percentage of filamentous and spherical virus particles
was determined by counting a minimum of 600 particles
in low-magnification micrographs of several different
preparations. Filamentous particles were defined as par-
ticles with a length of greater than 400 nm, which is
roughly 33 the observed diameter of spherical particles.
RESULTS
The 14C2 anti-M2 antibody inhibits A/Udorn filament
formation
The influenza A/Udorn/301/72 virus represents a strain
which has retained the capacity for viral filamentous
particle production despite passage in cell culture. Pre-
vious studies have shown that antibody to the M2 protein
can restrict growth and assembly of the A/Udorn virus
(Zebedee and Lamb, 1988, 1989; Hughey et al., 1995). To
further explore this inhibitory effect, we investigated the
assembly of filamentous particles at the surface of influ-
enza A/Udorn infected MDCK cells by surface immuno-
fluorescence.
As shown in Fig. 1a, numerous long filamentous viral
particles are observed in the process of budding at cell
surfaces when A/Udorn virus-infected cells were exam-
ined by surface immunofluorescence in the absence of
antibody treatment. The filamentous particles seen by
immunofluorescence correspond to the long filamentous
virus particles observed budding at the cell surface in
thin sections of A/Udorn infected cells (Hughey et al.,
1995; data not shown). In contrast, cells incubated in the
presence of the 14C2 antibody to the M2 protein (Fig. 1b)
were completely devoid of budding filaments, but
showed intense fluorescence, demonstrating the pres-
ence of viral antigens distributed over the cell surface.
The specificity of the effect of this antibody is shown by
the fact that a different monoclonal antibody (5C4) to the
M2 protein, which does not inhibit virus spread and is of
the same isotype, was found to have no inhibitory effect
on filament formation (Fig. 1c). To demonstrate further
the specificity of the inhibitory effect of the 14C2 anti-
body, we also examined the effect of antibody to another
viral surface protein, the NA protein. As seen in Fig. 1d,
cells incubated in the presence of antibody to NA con-
tinued to produce numerous long filamentous particles.
These results demonstrate that the inhibition of forma-
tion of filamentous virus particles is a specific effect of
the 14C2 anti-M2 antibody, which was previously shown
to inhibit the release of the A/Udorn virus. In the pres-
ence of 14C2 antibody, the morphology of released par-
ticles was found to be almost exclusively spherical (less
than 1% filamentous) when examined by negative stain-
ing and electron microscopy (Fig. 2). Thus, there appears
to be a correlation between antibody-induced inhibition
of virus growth and the inhibition of production of fila-
mentous particles.
In agreement with previous electron microscopy re-
sults (Hughey et al., 1995), we also observed that treat-
ment with the 14C2 antibody resulted in clustering of the
M2 antigen at the cell surface (Fig. 3b). However, we
found that similar clustering of cell surface M2 was also
observed with the M2-specific 5C4 monoclonal antibody
(Fig. 3c), but not in untreated cells (Fig. 3a). Both mono-
clonal antibodies recognize the N-terminal, extracellular
domain of the M2 protein. These results indicate that the
14C2 antibody-induced clustering of the M2 protein at
the cell surface is not responsible per se for the anti-
body-induced inhibition of virus release or filament for-
mation.
Antibody-resistant A/Udorn variants differ in
morphology
In order to examine further the role of the M2 protein
in virus assembly, we analyzed the assembly of three
plaque-purified variants of A/Udorn/301/72 virus, which
had been previously selected for resistance to the
growth inhibitory effects of the anti-M2 14C2 antibody
(Zebedee and Lamb, 1989). Antibody resistance in these
variants has been mapped to mutations in viral RNA
segment 7 and was shown to result from single amino
acid substitutions in either the M2 or the M1 proteins
(Zebedee and Lamb, 1989). The A/Udorn 5A variant has
a Lys78Gln amino acid substitution in the cytoplasmic
tail domain of the M2 protein, and the 10A variant has a
Ser71Tyr substitution, whereas the 1A variant has an
Ala41Val substitution in the M1 protein.
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At 9 h pi, MDCK cells infected with either the 5A or the
10A variants displayed intense staining of filamentous
particles emanating from the cell surface. Furthermore,
with both of these variants, no inhibition of filament
formation was observed in the presence of the inhibitory
14C2 anti-M2 antibody (not shown). Using antibodies to
specific viral structural proteins, these filamentous par-
ticles were found to contain HA, NA, NP, and M1 viral
antigens (Figs. 4b and 4c, and data not shown). Some
staining of the filamentous particles was also detected
with anti-M2 monoclonal antibodies (not shown). How-
ever, no F-actin could be detected in the viral filaments,
thus clearly distinguishing them from cellular microvilli.
In contrast to the results with the 5A and 10A variants, no
viral filaments were observed emanating from the cell
surface in MDCK cells infected with the 1A variant, even
though intense staining of the cell surface with viral
antiserum was evident (Fig. 4a). Thus, it appears that the
1A variant has lost its ability to produce filamentous
particles.
To further investigate the structure of released virions,
we examined the morphology of negatively stained virus
particles released into the media (Fig. 4, right). Both the
5A and the 10A variants were found to produce numer-
ous filamentous particles (Figs. 4e and 4f, respectively),
whereas exclusively spherical particles were observed
with the 1A variant (Fig. 4d). Thus, the mutation in the 1A
variant has resulted in the production of spherical rather
than filamentous particles.
We also observed that the percentage of filamentous
FIG. 1. Inhibition of filament formation by 14C2 anti-M2 antibody. MDCK cells were infected with A/Udorn virus at an m.o.i. of 3 plaque-forming units per
cell. Media containing a 1:100 dilution of normal goat serum (a), mouse anti-M2 14C2 ascites fluid (b), mouse anti-M2 5C4 ascites fluid (c), or goat anti-N2
polyclonal antisera (d) was added at 2.5 h pi and the infection was continued for an additional 6.5 h. At 9 h pi the cells were sequentially incubated with
guinea pig anti-Udorn antisera and FITC-conjugated rabbit anti-guinea pig Ig. Immunofluorescent staining was performed at 4°C and the cells were fixed
in 3% paraformaldehyde. Viral filaments are numerous in a, c, and d, but are absent in cells treated with anti-M2 14C2 ascites fluid.
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particles released from infected cells varied consider-
ably with the different variants. As shown in Table 1, the
1A variant produces exclusively spherical particles. The
5A variant virus population is composed of approxi-
mately 18% filamentous particles, which is similar to the
level observed for the parental A/Udorn virus. The 10A
variant yield, however, was found to be composed of
greater than 40% filamentous particles. These results
demonstrate that single amino acid substitutions in the
M1 or M2 proteins can either enhance or prevent fila-
mentous particle production.
A/Udorn variants differ in growth properties
It has been reported that serial passage of filamen-
tous strains in eggs results in variants which display
FIG. 2. Morphology of A/Udorn virus grown in the presence of anti-M2 14C2 antibody. MDCK cells were infected with A/Udorn virus at an m.o.i.
of 3 PFU/cell. Medium containing a 1:100 dilution of mouse anti-14C2 antibody or medium without antibody was added at 2.5 hpii and the infection
was continued for an additional 6.5 h. At 9 h pi, the supernatants were harvested and precleared of cell debris by centrifugation (500g, 10 min). The
virus in the supernatants was analyzed by electron microscopy after negative staining. Depicted are electron micrographs of virus released from cells
treated with anti-M2 14C2 antibody (A) or without antibody treatment (B). Viral filaments are numerous in untreated cells (B) but slightly elongated
spherical particles were produced in antibody-treated cells (A). Original magnification, 10,3003; bar, 1 mm.
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faster growth rates and yield higher titers (Burnet and
Lind, 1957; Kilbourne and Murphy, 1960). In at least
some cases this has been attributed to loss of the
filamentous phenotype (Burnet and Lind, 1957). Thus,
we expected that there might be significant differ-
ences in the growth properties of the A/Udorn variants.
When we compared the yields of the variant viruses
after infection of MDCK cells, we observed that the 1A
variant consistently yielded viral infectivity titers ap-
proximately 3.3- to 8.6-fold higher than those of either
the 5A or the 10A variants, respectively (Table 1). The
physical particle production as measured by hemag-
glutination assay also correlated with the infectivity
titers of the variants. These results indicate that the
spherical particles in the 1A variant are produced at
higher levels than the filamentous particles produced
by the other variants. No major differences were ob-
served in the levels of viral protein expression among
the variants (data not shown), indicating that differen-
tial protein expression is not the cause of the ob-
served growth differences. Although we can not rule
out that mutations in other genes may have occurred,
it seems likely that the specific amino acid substitu-
tions in M1 and/or M2 are responsible for the altered
phenotypes and growth characteristics.
Variant virus particles differ in physical and
biochemical characteristics
Little information has been obtained on the protein
composition of influenza virus filamentous particles. Ad-
ditionally, strains producing filaments also produce
spherical particles, which can complicate the interpreta-
tion of the results. We investigated the protein composi-
tion of the A/Udorn variant viruses after separation of
spherical and filamentous particles by velocity density
centrifugation.
After radiolabeling of virus from MDCK cells infected
with A/Udorn or variant viruses, the 35S-radiolabeled
particles were harvested and layered onto a 20–60%
sucrose gradient and separated by centrifugation. As
can be seen in Fig. 5, after fractionation of the gradi-
ents the distribution of radioactivity was largely con-
fined to fractions 8 to 13, but the distribution differed
for the variant viruses. The parental A/Udorn strain,
and the 5A and 10A variants, exhibited a heteroge-
neous profile as evidenced by the broad distribution of
radioactivity in fractions 8–13. In contrast, the 1A virus
sedimented much more homogeneously, with a major
peak in fractions 12 and 13. As shown in Fig. 6 (left),
pooled fractions 11–13 were found to be almost exclu-
sively composed of spherical particles. In contrast, the
faster sedimenting virus population (fractions 7–9) is
highly enriched in filamentous particles. We did not
observe any major differences in the specific infectiv-
ity ratios between the two virus populations (Table 2),
indicating that both filamentous virions and spherical
particles are similar in infectivity.
The virion protein profiles of the distinct particle
populations from fractions 8–13 were also compared
by polyacrylamide gel electrophoresis (Fig. 7). Inter-
estingly, two forms of viral NP appear to be present in
virus particles, which may represent different phos-
phorylated forms (Almond and Felsenreich, 1982; Kist-
ner et al., 1985, 1989). Quantitative analysis revealed
that lower NP levels were associated with filamentous
particles (fractions 8–9) than with spherical particles
(fractions 11–13), whereas the M1 to HA ratios were
similar in both populations of virions (Table 3). In
spherical particles the NP to M1 or HA ratio was
approximately 1:2. The NP to M1 or HA ratio in fila-
mentous particle fractions 8–9 ranged from 1:2.5 to
1:11 depending on the virus. The decrease in the
FIG. 3. Cell surface localization of viral M2 antigen after antibody treatment. MDCK cells were infected and treated with antibody during
infection as described in Fig. 1, and were sequentially incubated with anti-14C2 monoclonal antibody and FITC-conjugated goat anti-mouse Ig
at 8 h p.i. Depicted are: (a) cells not treated with antibody during infection; (b) cells treated with 1:100 dilution of 14C2 anti-M2 monoclonal
antibody from 2–8 h pi; and (c) cells treated with a 1:100 dilution of 5C4 anti-M2 from 2–8 h pi Immunofluorescent staining was performed at
4°C prior to fixation with 3% paraformaldehyde. The M2 antigen is evenly distributed across the cell surface in untreated cells (a), but clusters
in 14C2 or 5C4 anti-M2 antibody-treated cells.
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NP:M1 ratio does not indicate a reduction in the total
amount of NP per filamentous particle, however, since
the mass of a filamentous particle is much greater
than that of a spherical particle.
DISCUSSION
The filamentous phenotype is a genetic trait, which
can be transferred by reassortment between different
FIG. 4. Differences in morphology of A/Udorn variant viruses 1A, 5A and 10A. MDCK cells were infected for 9 hr with the A/Udorn varaint
viruses 1A, 5A, and 10A at an m.o.i. of 3. Cells were processed for indirect immunofluorescent cell surface staining of viral glycoproteins as
described under Materials and Methods using guinea pig anti-Udorn antisera and FITC-conjugated rabbit anti-guinea pig Ig (left). Micrographs
of negatively stained virus from the supernatants of infected cells are depicted at the right, Magnification 5 86003. Viral filaments are
numerous in 5A (b, e) and 10A-infected cells (c, f), but are not observed in 1A variant-infected cells (a, d). Bar, approximately 1.2 mm.
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influenza A viruses (Choppin, 1963; Choppin et al., 1960;
Kilbourne and Murphy, 1960; Smirnov et al., 1991). The
filamentous phenotype is often lost upon low-dilution
serial passage of virus in eggs (Burnet and Lind, 1957). In
this report, we present evidence that the viral M1 and M2
proteins can modulate viral morphology. Genetic reas-
sortment studies between filamentous and spherical vi-
rus strains have also suggested that the gene products
of segment 7 play a major role in regulation of the
morphological phenotype of influenza A virus (Smirnov et
al., 1991). We observed loss of the filamentous phenotype
in a variant with an alanine to valine substitution in the
M1 protein at position 41. This Ala41Val substitution in
the M1 protein is also found in other strains, including
A/WSN/33 and A/PR8/34, both of which produce largely
spherical particles (Winter and Fields, 1980; Zebedee
and Lamb, 1989). However, these strains have under-
gone extensive laboratory adaptation, which may have
led to additional mutations affecting morphology. Com-
parison of the M1 proteins of various avian and human
strains of influenza did not reveal a direct correlation
between the presence of valine at position 41 and spher-
ical morphology. However, there is very little information
regarding the passage history of viruses with known
sequences, and other mutations resulting in spherical
morphology may have arisen during passage.
Recently, Mitnaul and co-workers (1996) reported that
deletion of the cytoplasmic tail of the influenza virus NA
protein led to a shift from a spherical to a filamentous
phenotype. A much greater shift toward filamentous par-
ticle production was observed when the cytoplasmic tail
TABLE 1
Growth Characteristics of A/Udorn Variant Viruses
Virus PFU/mla HAU/ml
PFU/HAU
(Log10) % F-virions (n)
b
Udorn 4.3 3106 (60.5) 512 3.92 15 (n5 753)
1A 2.4 3106 (60.2) 512 3.69 ,2 (n5 622)
5A 7.3 3105 (60.04) 256 3.44 18 (n5 624)
10A 2.8 3105 (60.02) 128 3.34 46 (n51214)
a The plaque-forming units per milliliter were determined by plaque
assay in MDCK cells in the presence of trypsin (1.5 mg/ml). The
standard error of the mean in shown in parentheses. The Student t test
analysis reveals significant differences between all variant viruses
compared to the A/Udorn virus (P , 0.05). The values obtained for the
1A variant were highly significant when compared to the variants 5A
and 10A (P , 0.01 and P , 0.001, respectively.)
b The percentage of filamentous particles was determined as de-
scribed under Materials and Methods. A minimum of 600 particles per
variant were counted (n).
FIG. 5. Sedimentation profiles of variant viruses. 35S-radiolabeled virus (A/Udorn or variant viruses 1A, 5A, or 10A) was analyzed by velocity gradient
centrifugation in 20–60% sucrose gradients. Gradients were fractionated and the cpm per fraction was determined by scintillation counting of fraction
aliquots.
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domains of both the NA and the HA were deleted (Jin et
al., 1997). However, the particles produced with these
mutants differ from the filamentous A/Udorn particles, in
that particles of abnormal diameter and greatly dis-
tended structures were frequently observed. Interactions
between the cytoplasmic tails of the viral glycoproteins
and the matrix (M1) protein are likely to be essential for
accurate assembly of virions with either the spherical or
the normal filamentous morphology.
The present results indicate that the viral M2 protein
also plays a role in regulating viral morphology. We
observed previously that the 14C2 M2-specific antibody
can restrict virus growth by inhibiting virus assembly and
release (Hughey et al., 1995). Treatment of cells with this
M2 antibody dramatically suppresses filamentous parti-
cle production, but does not prevent the assembly and
release of spherical particles. The mechanism by which
anti-M2 antibody restricts virus growth and filamentous
particle formation is still not clear. Several lines of evi-
dence indicate that the cytoplasmic tail domain of the M2
protein and not the ion channel activity is involved in
modulating virus morphology: (i) the ion channel activity
of the M2 protein is not influenced by 14C2 M2-specific
antibody binding (Holsinger, Pinto, and Lamb, unpub-
lished observations); (ii) amantadine treatment failed to
inhibit filamentous particle formation (data not shown);
and (iii) antibody-resistant filamentous variants have mu-
tations in the M2 cytoplasmic tail domain. These results
suggest that the cytoplasmic domain of the M2 protein
may undergo a conformational change due to antibody
FIG. 6. Morphology of A/Udorn virus after gradient fractionation. Virus from a/Udorn infected cells at 16 h. p. i. was harvested, pelleted by
ultracentrifugation, and separated by velocity centrifugation in 20–60% sucrose gradients. After fractionation, pooled fractions of virus were pelleted
and analyzed by electron microscopy after negative staining. Depicted are electron micrographs of filamentous (fractions 7–9, right) and spherical
(fractions 11–13, left) particles. Original magnification 5 13,0003 (right) and 27,6003 (left); bar, approximately 0.6 and 0.3 m, respectively.
TABLE 2
Infectivity of Filamentous and Spherical Particles
Virus
F-fractions S-fractions
PFU/ml
(3108)
PFU/mg of viral
protein (3108)
PFU/ml
(3108)
PFU/mg of viral
protein (3108)
Udorn 10.5 2.4 20.5 4.1
Note. Virus harvested from MDCK cells was pelleted and layered
over a 20–60% sucrose gradient. Following velocity centrifugation and
fractionation, fractions 7–9 and 11–13 were pooled to represent frac-
tions enriched in filamentous (F) and spherical (S) particles, respec-
tively. Aliquots of pooled fractions were analyzed for infectivity by
plaque assay on MDCK cells in the presence of 1.5 mg/ml TPCK–
trypsin. Protein concentrations were determined using the Micro BCA
Protein Assay (Pierce, Rockford, IL).
FIG. 7 Protein composition of filamentous and spherical virus
particles. Radiolabeled virus from fractions 8–13 as shown in Fig. 5
was analyzed by SDS–PAGE (10%) and fluorography. The identity of
specific viral protein bands is indicated on the right.
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binding, which possibly affects protein interactions in-
volved in filament formation. This also suggests that the
M2 and M1 proteins may undergo a transient associa-
tion which is necessary for filamentous particle produc-
tion. Association of M1 with M2 may maintain the M1
protein in a conformation which favors elongation of viral
budding.
The data presented here also suggest that another
mechanism for anti-M2 antibody resistance may be
linked to the loss of the F-phenotype. This is suggested
by the results obtained for the 1A variant, which codes
for the wild-type antibody-sensitive M2 protein but codes
for an M1 protein with a single amino acid substitution
and produces spherical particles. This hypothesis is fur-
ther supported by the fact that other virus strains which
are resistant to anti-M2 antibody inhibitory effects, such
as the WSN and PR8 strains of influenza A virus, produce
predominantly spherical particles. It will therefore be of
interest to determine if spherical morphology is sufficient
to confer resistance to inhibition by M2 antibody.
The actin cytoskeletal network may also interact with
the M2 or M1 proteins during filamentous particle pro-
duction. We have demonstrated that filament formation
depends upon an intact actin microfilament array (Rob-
erts and Compans, 1997). Disruption of that array leads
to a shift from filamentous to spherical particle produc-
tion. The M1 and the NP protein have both been reported
to interact with the cytoskeleton of host cells (Avalos et
al., 1997).
It has been suggested that filamentous forms of virus
may exhibit a higher specific infectivity than spherical
particles (Ada et al., 1958; Smirnov et al., 1991). Although
we observed that the percentage of NP is reduced in
filaments, this does not mean that the incorporation of
RNP cores per particle is reduced in filamentous parti-
cles. The mass of a filamentous particle 10 mm in length
with a diameter of 120 nm is approximately 100-fold
greater than that of a small spherical particle. A small
spherical particle is estimated to contain approximately
1000 molecules of NP per particle based on protein
composition and estimates of particle mass (Choppin
and Compans, 1975). Based on the difference in ratios of
NP to M1 between spherical and filamentous particles
(Table 3), filamentous A/Udorn particles contain approx-
imately 60% of the relative NP amount found for spherical
particles. Based on the relative particle mass and as-
suming that a filament is composed of 70% protein
(Scholtissek et al., 1969), then a filamentous particle
would contain approximately 56,000 molecules of NP.
Thus, the amount of NP is estimated to be 56-fold higher
in a 10-mm filamentous particle than in a 120-mm spher-
ical particle. This is consistent with previous results of
Smirnov and co-workers (1991), who found no significant
differences in RNA content between spherical and fila-
mentous particle-enriched fractions. In fact, it is likely
that the infectivity observed for the fractions enriched in
filaments after sucrose gradient separation was reduced
due to fragility of the long filamentous particles upon
ultracentrifugation (Table 2).
The filamentous variants possess many of the charac-
teristics described for newly isolated human strains of
virus (Kilbourne, 1963; Kilbourne and Murphy, 1960). They
produce smaller plaques and yield lower titers than the
laboratory-adapted strains. Previous work has demon-
strated that egg adaptation of newly isolated strains
increases viral yields, an important prerequisite for use
of a strain in vaccine development (Kilbourne and Mur-
phy, 1960). Segment 7 encoded proteins have also been
correlated to high-yielding properties of some viral
strains (Klimov et al., 1991). It is interesting to note that
segment 7 gene products have also been implicated in
limitation of avian influenza viruses to growth in the
respiratory tract of primates (Buckler-White et al., 1986;
Tian et al., 1985). It will be interesting to determine
whether differences in morphology could play a role as a
determinant of influenza viral pathogenesis.
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